Drug information for VALSARTAN AND HYDROCHLOROTHIAZIDE
Form
Dosage
Status
Therapeutic Equivalence
Active Ingred
Ref.
Sponsor
Document
TABLET; ORAL
160MG; 25MG
Tentative Approval
VALSARTAN
;
HYDROCHLOROTHIAZIDE
Exforge HCT
MYLAN PHARMA
78020
TABLET; ORAL
160MG;12.5MG
Tentative Approval
VALSARTAN
;
HYDROCHLOROTHIAZIDE
Exforge HCT
MYLAN PHARMA
"
TABLET; ORAL
320MG; 12.5MG
Tentative Approval
VALSARTAN
;
HYDROCHLOROTHIAZIDE
Exforge HCT
MYLAN PHARMA
"
TABLET; ORAL
320MG; 25MG
Tentative Approval
VALSARTAN
;
HYDROCHLOROTHIAZIDE
Exforge HCT
MYLAN PHARMA
"
TABLET; ORAL
80MG;12.5MG
Tentative Approval
VALSARTAN
;
HYDROCHLOROTHIAZIDE
Exforge HCT
MYLAN PHARMA
"
Drug Adverse Effects information for VALSARTAN AND HYDROCHLOROTHIAZIDE
Role code
Indications
Reaction
# Reports
C
ACUTE LEUKAEMIA
CYTOLYTIC HEPATITIS
2
C
ACUTE LEUKAEMIA
DIALYSIS
2
C
ACUTE LEUKAEMIA
FEBRILE BONE MARROW APLASIA
2
C
ACUTE LEUKAEMIA
RENAL FAILURE
2
C
ACUTE LEUKAEMIA
SEPTIC SHOCK
2
C
ACUTE LEUKAEMIA
VENOOCCLUSIVE LIVER DISEASE
2
C
LEUKAEMIA
CYTOLYTIC HEPATITIS
1
C
LEUKAEMIA
DIALYSIS
1
C
LEUKAEMIA
FEBRILE BONE MARROW APLASIA
1
C
LEUKAEMIA
RENAL FAILURE
1
C
LEUKAEMIA
SEPTIC SHOCK
1
C
LEUKAEMIA
VENOOCCLUSIVE LIVER DISEASE
1
C
TYPE 2 DIABETES MELLITUS
BLADDER TRANSITIONAL CELL CARCINOMA
1
Ads by Google